A micellar liquid chromatography method for the quantification of abacavir, lamivudine and raltegravir in plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 98, Issue , 2014, Pages 351-355

  Peris Vicente, Juan ^a   Villareal Traver, Mónica ^a   Casas Breva, Inmaculada ^b   Carda Broch, Samuel ^a   Esteve Romero, Josep ^a  

^a UNIVERSITAT JAUME I   (Spain)

^b HOSPITAL DE LA PLANA   (Spain)

Author keywords

Antiretroviral; Immunodeficiency; Micellar; Plasma; Validation

Indexed keywords

ABACAVIR; DODECYL SULFATE SODIUM; LAMIVUDINE; RALTEGRAVIR; 2 PYRROLIDONE DERIVATIVE; 2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ANTIRETROVIRUS AGENT; MICELLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS PATIENT; ARTICLE; BLOOD SAMPLING; CALIBRATION; DRUG BLOOD LEVEL; DRUG STRUCTURE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MICELLAR LIQUID CHROMATOGRAPHY; PH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; ROOM TEMPERATURE; THIN LAYER CHROMATOGRAPHY; BLOOD; CHEMISTRY; LIQUID CHROMATOGRAPHY; MICELLE; PLASMA; PROCEDURES;

ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHROMATOGRAPHY, LIQUID; DIDEOXYNUCLEOSIDES; LAMIVUDINE; MICELLES; PLASMA; PYRROLIDINONES; SODIUM DODECYL SULFATE;

EID: 84903747118     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.06.009     Document Type: Article

References (23)

1. Popovic M., Sarngandharan M.G., Read E., Gallo R.C. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science 1984, 224:497-500.
2. Volsky D.J., Sakai K., Stevenson M., Dewhurst S. Retroviral etiology of the acquired immune deficiency syndrome (AIDS). AIDS Res. 1986, 2:s35-s48.
3. Casas Breva I., Peris-Vicente J., Rambla-Alegre M., Carda Broch S., Esteve-Romero J. Monitoring of HAART regime antiretrovirals in serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography. Analyst 2012, 137:4327-4334.
4. Raviolo M.A., Casas-Breva I., Esteve-Romero J. Screening and monitoring antiretrovirals and antivirals in the serum of acquired immunodeficiency syndrome patients by micellar liquid chromatography. J. Chromatogr. A 2009, 1216:3546-3552.
5. Law V., Knox C., Djoumbou Y., Jewison T., Guo A.C., Liu Y., Maciejewski A., Arndt D., Wilson M., Neveu V., Tang A., Gabriel G., Ly C., Adamjee S., Dame Z.T., Han B., Zhou Y., Wishart D.S. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 2014, 42:D1091-S1097. Available at: http://www.drugbank.ca/ (Accessed: 16.04.14).
6. Fabbiani M., Mondi A., Colafigli M., D'Ettorre G., Paoletti F., D'Avino A., Ciccarelli N., Sidella L., Murri R., Fortuna S., Vullo V., Cauda R., De Luca A., Di Giambenedetto S. Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study). Scand. J. Infect. Dis. 2014, 46:34-45.
7. Li B.Q., Niu B., Chen L., Wei Z.J., Huang T., Jiang M., Lu J., Zheng M.Y., Kong X.Y., Cai Y.D. Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network. PLoS ONE 2013, 8:e65207.
8. Mouscadet J.F., Tchertanov L. Raltegravir: molecular basis of its mechanism of action. Eur. J. Med. Res. 2009, 14:5-16.
9. Rezk N.L., Tidwell R.R., Kashuba A.D.M. Simultaneous determination of six HIV nucleoside analogue reverse transcriptase inhibitors and nevirapine by liquid chromatography with ultraviolet absorbance detection. J. Chromatogr. B 2003, 791:137-147.
10. Garcia de Olalla P., Knobel H., Carmona A., Guelar A., Lopez-Colomes J.L., Cayla J.A. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients. J. Acq. Imm. Def. Synd. 2002, 30:105-110.
11. The Immunoassay Handbook, Fourth Edition: Theory and applications of ligand binding, ELISA and related techniques 2013, Elsevier, Amsterdam, The Netherlands. D.G. Wild (Ed.).
12. Notari S., Tommasi C., Nicastri E., Bellagamba R., Tempestilli M., Pucillo L.P., Narciso P., Ascenzi P. Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC-UV. IUBMB Life 2009, 61:470-475.
13. Lakshmana Rao A., Raghu Ram M.S. Validated reverse phase HPLC method for determination of raltegravir in pharmaceutical preparations. IJRPC 2012, 2:217-221.
14. Gomes N.A., Pudage A.M., Joshi S.S., Vaidya V.V. S.A. LC-MS-MS method for simultaneous analysis of abacavir and lamivudine in human plasma, and its application to a bioequivalence study. Chromatographia 2008, 68:541-550.
15. Fromentin E., Gavegnano C., Oblikhod A., Schinazi R.F. Simultaneous quantification of intracellular natural and antiretroviral nucleosides and nucleotides by liquid chromatography-tandem mass spectrometry. Anal. Chem. 2010, 82:1982-1989.
16. Kenney K.B., Wring S.A., Carr R.M., Wells G.N., Dunn J.A. Simultaneous determination of zidovudine and lamivudine in human serum using HPLC with tandem mass spectrometry. J. Pharm. Biomed. Anal. 2000, 22:967-983.
17. Esteve-Romero J., Ochoa-Aranda E., Bose D., Rambla-Alegre M., Peris-Vicente J., Martinavarro-Domínguez A. Tamoxifen monitoring studies in breast cancer patients by micellar liquid chromatography. Anal. Bioanal. Chem. 2010, 397:1557-1561.
18. Rambla-Alegre M., Peris-Vicente J., Esteve-Romero J., Carda-Broch S. Analysis of selected veterinary antibiotics in fish by micellar liquid chromatography with fluorescence detection and validation in accordance with regulation 2002/657/EC. Food Chem. 2010, 123:1294-1302.
19. ICH Expert Working Meeting, ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodologies Q2(R1), Geneva, Switzerland (2005) Available at: (Last accessed 16.04.14). http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf.
20. Marco-Peiró S., Beltrán-Martinavarro B., Rambla-Alegre M., Peris-Vicente J., Esteve-Romero J. Validation of an analytical methodology to quantify melamine in body fluids using micellar liquid chromatography. Talanta 2012, 88:617-622.
21. Rambla-Alegre M., Peris-Vicente J., Marco-Peiró S., Beltrán-Martinavarro B., Esteve-Romero J. Development of an analytical methodology to quantify melamine in milk using micellar liquid chromatography and validation according to EU Regulation 2002/654/EC. Talanta 2010, 81:894-900.
22. Torres-Lapasió J.R. Michrom Software 2000, Marcek-Dekker, New York, USA.
23. Beltrán-Martinavarro B., Peris-Vicente J., Marco-Peiró S., Esteve-Romero J., Rambla-Alegre M., Carda-Broch S. Use of micellar mobile phases for the chromatographic determination of melamine in dietetic supplements. Analyst 2012, 137:269-274.